Statins, medications designed to lower cholesterol, do not meaningfully alter the risk of death or disease progression in people with…
Articles by Marisa Wexler, MS
Differences in the inflammatory activity of certain immune cells may explain why amyotrophic lateral sclerosis (ALS) progresses faster in…
An international team of scientists has developed an RNA-based experimental medicine that has the potential to reduce clumping of the…
Following a recent meeting with the U.S. Food and Drug Administration (FDA), Clene is planning to submit an application…
People with amyotrophic lateral sclerosis (ALS) who received a high dose of the experimental therapy dazucorilant had a significantly…
In France, the average family impacted by amyotrophic lateral sclerosis (ALS) has to pay thousands in out-of-pocket expenses to…
The Muscular Dystrophy Association (MDA) will return to New York City on June 4 for its 26th annual Wings…
Nearly half of the people with amyotrophic lateral sclerosis (ALS) treated with masitinib in a clinical trial survived…
Long-term exposure to air pollution is not associated with an altered, or increased, risk of amyotrophic lateral sclerosis (ALS).
As part of preparations for a Phase 3 clinical trial to test its experimental therapy, masitinib, in people with amyotrophic…